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Online Appendix 1. Survey questions for canadian critical care pharmacists about medication errors 
and adverse drug events
1. Name of institution (without identifying respondents)
2. Type of institution
• Academic hospital
• Community hospital, teaching 
• Community hospital, non-teaching
3. Type of ICU in which you spend most of your time (choose one)
• Mixed medical/surgical
• Medical
• Surgical
• Coronary
• Neonatal
• Cardiothoracic
• Pediatric
• Neurologic
• Trauma
• Burns
4. How many funded ICU beds are there in the ICU in which you
work?
• 1–10
• 11–20
• 21–30
5. Does your ICU have a pharmacist who is familiar with the ICU
patients’ conditions, and who reviews the patients’ drug therapy
with the ICU team at least 5 days a week, during day time hours?
Yes/No
6. Does your hospital have computerized physician order entry?
Yes/No
7. Does the software include decision support? Yes/No
8. Does your ICU have a process for tracking medication errors and
adverse drug events? Yes/No
9. Please identify the locations where the process for tracking 
medication errors is implemented.
• The process is specific to the ICU that I spend the most of
my time in.
• This process is used in more than one area of the hospital.
• This process is used throughout the majority of the hospital.
• Other (please specify)
10.Please identify which of the following processes your ICU uses
for identifying medication errors 
• Voluntary reporting of medication errors, non-anonymous
• Direct observation of medication errors (i.e., ordering and/
or administration)
• Voluntary reporting of medication errors, anonymous
• Chart reviews to identify medication errors
• Computerized system to identify medication errors
• Trigger tool (a list of prompts used in focused chart review 
to identify medication errors and adverse drug events)
• Tracking pharmacist interventions as a marker of medication
errors and potential adverse drug events
• Other (please specify)
11.If voluntary reporting of medication errors is used, please specify
which means 
• Paper reports
• Intranet
• Phone calls
• Web-based or internet based
• Email
• Other (please specify)
12.Please specify the Web-based or internet based system
• Netsafe
• Meditech-EMR
• Risk MonitorPro
• Unknown
13.If a trigger tool is used by your ICU, please identify which 
of the following are used as the trigger signals 
• Voluntarily reported medication errors
• Abnormal drug levels (e.g., digoxin level > 2.6 nmol/L)
• Antidotes (e.g., vitamin K, naloxone)
• Allergy medications (e.g., diphenhydramine, corticosteroids)
• Abnormal laboratory values (e.g., INR > 6, serum glucose 
< 3 mmol/l)
• Abrupt medication stop
• Abnormal electrolyte concentrations
• Antidiarrheals or Clostridium difficile positive stool
• Abnormal physiologic responses (BP, HR)
• Other (please specify)
14.Have you implemented any actions as a result of your process for
measuring medication errors and/or adverse drug events? Yes/No
15.What actions have you implemented?
16.Would you like a summary of the results of the survey?
BP = blood pressure, HR = heart rate, ICU = intensive care unit, 
INR = international normalized ratio.
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